AWP
ABBV icon

Axis Wealth Partners’s AbbVie ABBV Stock Holding History

Axis Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$396K Buy
1,821
+45
+3% +$9.98K 0.21% 118
2025
Q4 		$406K Sell
1,776
-39
-2% -$8.88K 0.22% 118
2025
Q3 		$420K Buy
1,815
+128
+8% +$26.1K 0.25% 108
2025
Q2 		$313K Sell
1,687
-88
-5% -$16.4K 0.21% 115
2025
Q1 		$372K Buy
1,775
+4
+0.2% +$778 0.27% 98
2024
Q4 		$315K Buy
+1,771
New +$326K 0.27% 100

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axis Wealth Partners's ABBV Position: Q1 2026 in Review

Axis Wealth Partners increased its AbbVie (ABBV) stake by 2.5% in Q1 2026, buying an estimated $9.98K and bringing the position to 1,821 shares worth $396K. The position accounts for 0.21% of the portfolio, ranked #118.

Axis Wealth Partners first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $420K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Axis Wealth Partners held 1,821 shares of AbbVie worth $396K as of Q1 2026.
  • Axis Wealth Partners bought 45 AbbVie shares in Q1 2026, an estimated $9.98K.
  • AbbVie made up 0.21% of Axis Wealth Partners's portfolio in Q1 2026, its #118 holding.
  • Axis Wealth Partners first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Axis Wealth Partners's AbbVie position peaked at $420K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Axis Wealth Partners's 13F filing for Q1 2026, filed 24 Apr 2026.